FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CRYO CELL INTERNATIONAL INC
2. Issuer Name and Ticker or Trading Symbol

CBA Florida, Inc. [ CBAI ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

700 BROOKER CREEK BLVD., SUITE 1800, 
3. Date of Earliest Transaction (MM/DD/YYYY)

2/19/2020
(Street)

OLDSMAR, FL 34677
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock         114207446 (1)(5)D  
Common Stock         5614932 (2)(5)D  
Common Stock         4061770 (3)(5)D  
Common Stock 2/19/2020  S  2683518 (4)D$0.0085 12316482 (4)(5)D  
Common Stock 2/20/2020  S  2316482 (4)D$0.0085 10000000 (4)(5)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Shares owned solely by cryo-cell International, Inc.
(2) Shares owned solely by David I. Portnoy.
(3) Shares owned solely by Mark L. Portnoy.
(4) Shares owned solely by George Gaines.
(5) Messrs. Portnoy, Portnoy and Gaines, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
CRYO CELL INTERNATIONAL INC
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

X

PORTNOY DAVID
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

XCo-Chief Executive Officer
Portnoy Mark L.
700 BROOKER CREEK BLVD.
ST. 1800
OLDSMAR, FL 34677

XCo-Chief Executive Officer
Gaines George
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

X


Signatures
/s/ David Portnoy, Individual, and Chief Executive Officer and Authorized Representative of Cryo-Cell, International, Inc.2/21/2020
**Signature of Reporting PersonDate

/s/ David Portnoy2/21/2020
**Signature of Reporting PersonDate

/s/ Mark Portnoy2/21/2020
**Signature of Reporting PersonDate

/s/ George Gaines2/21/2020
**Signature of Reporting PersonDate